Stock Screener App

Gratuito -

Installare

23.20

2.10% -0.58

Spyre Therapeutics Inc (SYRE)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Spyre Therapeutics Inc Azioni (SYRE) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	21.71% 41.94	53.57	55.39	44.15	47.77
Operating Income/Loss	21.71% -41.94	-53.57	-55.39	-44.15	-47.77
Nonoperating Income/Loss	40.56% 5.218	8.779	-13.62	5.31	3.949
Income/Loss From Continuing Operations Before Tax	18.02% -36.72	-44.79	-69.01	-38.84	-43.83
Income Tax Expense/Benefit	100.00% -	-0.015	0.018	-	0.032
Income/Loss From Continuing Operations After Tax	17.99% -36.72	-44.77	-69.03	-38.84	-43.86
Net Income/Loss	17.99% -36.72	-44.77	-69.03	-38.84	-43.86
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.95

1.55%

GMAB

$29.25

1.67%

INCY

$103.15

1.52%

BNTX

$103.91

0.05%

ONC

$313.50

0.34%

INSM

$184.91

0.58%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters